Abstract:Genetic pleiotropy, the phenomenon of a single gene or a single genetic variant influencing multiple phenotypes, appears to be pervasive in human genome. Thousands of genome-wide association studies (GWASes) have identified hundreds of thousands of genetic variants associated with hundreds of complex traits or diseases. Watanabe et al. (2019) systematically analyzed more than 4,000 publicly available GWASes, indicating the presence of widespread pleiotropy at the levels of genes (63%) and SNPs (31%). Identification of pleiotropic effects may help to explain the observations for shared heritability and comorbidity among multiple complex traits and shed light on the underlying biological mechanisms for those traits. However, progress in the identification and understanding of genetic pleiotropic effects remains limited. Indeed, the associations of genetic loci withmultiple traits observed inGWAS studies are cross-phenotype associations, which are distinguished from pleiotropic effects. Solovieff et al. (2013) described three broad categories of pleiotropy in the context of complex traits: biological pleiotropy, mediated pleiotropy and spurious pleiotropy. In recent years, with the increasing publicly availability of GWAS summary statistics, a number of statistical methods have been developed to evaluate the genetic overlap between multiple traits and diseases. Existing multi-trait methods can be broadly divided into multivariate methods and univariate methods (Hackinger and Zeggini, 2017). Univariate methods combine single-trait GWAS summary statistics to detect pleiotropic genetic variants. On the contrary, multivariate methods analyze all of the interesting traits in a unified model, which often require that individuallevel genotype and phenotype data for all traits analyzed (Hackinger and Zeggini, 2017). Although existing statistical methods are available for detecting pleiotropic effects, it is still very challenging for systematic characterization of pleiotropy. New methodologies are highly demanding for interpreting the results of cross-phenotypes associations. In the research topic on “Genetic Pleiotropy in Complex Traits and Diseases,” eight original studies are collected. It mainly focuses on the field of novel methodology development, identification of novel pleiotropic loci and the pathogenic mechanism of gene polymorphism in complex diseases. Specifically, three studies focus on the development of novel methodology for detecting multitraits associations based on GWAS summary data. Liu et al. presented powerful procedures to jointly analyze multiple traits based on GWAS summary statistics. They first adopted the generalized BerkJones (GBJ) test and the generalized higher criticism (GHC) test to analyze multiple traits and then combined the p-values of GBJ, GHC and the existing MinP (the minimum of the p-values) test by the aggregated Cauchy association test, namely omnibus (OMNI) test. The proposed tests can well control the type I error rate and the OMNI test is robust to the signal directions, the correlation structures and the degrees of sparsity. Replication plays a key role in evaluating the credibility of pleiotropic effects. Ning et al. evaluated four methods for replicating multi-trait associations and Edited and reviewed by: Simon Charles Heath, Center for Genomic Regulation (CRG), Spain

Effect heterogeneity reveals complex pleiotropic effects of rare coding variants

Rare variant contribution to human disease in 281,104 UK Biobank exomes

Systematic single-variant and gene-based association testing of thousands of phenotypes in 394,841 UK Biobank exomes

Genetic associations of protein-coding variants in human disease

Protein-altering variants at copy number-variable regions influence diverse human phenotypes

Polygenic architecture of rare coding variation across 394,783 exomes

Rare coding variant analysis for human diseases across biobanks and ancestries

Investigation of recessive effects of coding variants on common clinical phenotypes in exome-sequenced UK Biobank participants

Transcript-aware analysis of rare predicted loss-of-function variants in the UK Biobank elucidate new isoform-trait associations

Allelic Expression of Deleterious Protein-Coding Variants Across Human Tissues

Editorial: Genetic Pleiotropy in Complex Traits and Diseases

Specificity, length, and luck: How genes are prioritized by rare and common variant association studies

Genome-wide large-scale multi-trait analysis characterizes global patterns of pleiotropy and unique trait-specific variants

The functional impact of rare variation across the regulatory cascade

Impact of Rare Non-coding Variants on Human Diseases through Alternative Polyadenylation Outliers

The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease

Joint analysis of individual-level and summary-level GWAS data by leveraging pleiotropy

Association Analysis and Meta-Analysis of Multi-Allelic Variants for Large-Scale Sequence Data

Rare variant associations with plasma protein levels in the UK Biobank

Methods for Association Analysis and Meta‐Analysis of Rare Variants in Families

LPG: a four-groups probabilistic approach to leveraging pleiotropy in genome-wide association studies